Copyright
©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 111384
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.111384
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.111384
Table 1 The American Society for Gastrointestinal Endoscopy and adverse events in gastrointestinal endoscopy categories for potential adverse events
| ASGE | AGREE | ||
| Grading | Definition | Grading | Definition |
| Mild | Procedure aborted (or not started) because of an adverse event | No adverse event | A telephone contact with the general practitioner, outpatient clinic, or endoscopy service without any intervention |
| Extended observation of the patient after the procedure, < 3 hours, without any intervention | |||
| Postprocedure medical consultation | Grade I | Adverse events with any deviation of the standard postprocedural course, without the need for pharmacologic treatment or endoscopic, radiologic, or surgical interventions | |
| Unplanned hospital admission or prolongation of hospital stay for 3 nights | Presentation at the emergency ward, without any intervention | ||
| Hospital admission (< 24 hours), without any intervention | |||
| Allowed therapeutic regimens are drugs as antiemetics, antipyretics, analgesics, and electrolytes | |||
| Allowed diagnostic tests: Radiology and laboratory tests | |||
| Moderate | Unplanned anesthesia/ventilation support, i.e., endotracheal intubation during conscious sedation | Grade II | Adverse events requiring pharmacologic treatment with drugs other than those allowed for grade I adverse events (i.e., antibiotics, antithrombotics, etc.) |
| Unplanned admission or prolongation for 4-10 nights | |||
| ICU admission for 1 night | Blood or blood product transfusions | ||
| Transfusion | Hospital admission for more than 24 hours | ||
| Repeat endoscopy for an adverse event | Grade III | Adverse events requiring endoscopic, radiologic, or surgical intervention | |
| Interventional radiology for an adverse event | Grade IIIa | Endoscopic or radiologic intervention | |
| Interventional treatment for integument injuries | Grade IIIb | Surgical intervention | |
| Severe | Unplanned admission or prolongation for > 10 nights | Grade IV | Adverse events requiring intensive care unit/critical care unit admission |
| ICU admission > 1 night | Grade IVa | Single-organ dysfunction (including dialysis) | |
| Surgery for an adverse event | Grade IVb | Multiorgan dysfunction | |
| Permanent disability (specify) | |||
| Fatal | Death | Grade V | Death of the patient |
Table 2 Frequencies of adverse events in gastrointestinal endoscopy categories for potential adverse events in diagnostic and therapeutic procedures, n (%)
| AGREE categories | Diagnostic procedures (n = 114) | Therapeutic procedures (n = 121) |
| No adverse event | 75 (65.79) | 33 (27.73) |
| Grade I | 6 (5.26) | 3 (2.52) |
| Grade II | 21 (18.42) | 35 (29.41) |
| Grade III | 9 (7.89) | 35 (29.41) |
| Grade IV | 2 (1.75) | 3 (2.52) |
| Grade V | 1 (0.88) | 12 (10.08) |
Table 3 Comparison between the American Society for Gastrointestinal Endoscopy and adverse events in gastrointestinal endoscopy classification systems
| Feature | ASGE lexicon | AGREE classification |
| Definition | An event that prevents completion of the planned procedure and/or results in admission to hospital, prolongation of existing hospital stay, another procedure (needing sedation/anesthesia), or subsequent medical consultation | A negative outcome for the patient that prevents completion of a planned procedure or causes any deviation from the standard postprocedural course |
| Severity categories | Mild, moderate, severe, fatal | Grades 1 to 5 (based on clinical impact, management, and outcome) |
| Also, it qualifies for all events timing and attribution | ||
| Applicability | All gastrointestinal endoscopy procedures | All gastrointestinal endoscopy procedures |
| Adopted historically | Should enable comparison between GI endoscopy and surgery or interventional radiology | |
| Focus on hospital admission and postprocedural interventions | Focus on postprocedural interventions | |
| Origin | United States and Canada | Worldwide |
- Citation: Corsi O, Martinez R, Aguirre J, Friedrich I, Galeno V, Jimenez V, Briones P, Díaz LA, Espino A, Vargas JI. Application of a novel adverse event classification scale in a Latin American gastrointestinal endoscopy unit. World J Gastrointest Endosc 2026; 18(1): 111384
- URL: https://www.wjgnet.com/1948-5190/full/v18/i1/111384.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i1.111384
